profit from every IDR 100 of sales.
IDR 0IDR 100
PT Medikaloka Hermina Tbk
IDR 494.00+2.92% today
-65.8% in 1 year
1-year low IDR 468.001-year high IDR 1,465.00
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average.
0%20% a year
You pay IDR 17.53 for every IDR 1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
PT Medikaloka Hermina Tbk vs. similar companies
PT Medikaloka Hermina Tbk grows in the middle of these 5 and is priced in the middle for its profits.
| Company | Profit from IDR 100 of sales | Sales growth a year | Price per IDR 1 of profit |
|---|---|---|---|
| PT Medikaloka Hermina Tbk | 17.5× · Fair price | ||
 HCA Healthcare | 15.4× · Fair price | ||
 Fresenius SE & Co. KGaA | 23.9× · Fair price | ||
 IHH Healthcare Berhad | 34.3× · Expensive | ||
 Rede D'Or São Luiz | 16.2× · Fair price |
AI analysis
An AI analyst reads PT Medikaloka Hermina Tbk's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisNo annual statements on file yet.
Valuation
- 17.5×
- –
- 1.48
- 2.3×
- 1.1×
- –
- –
- -8.1%
- 5.7%
- –
Profitability
- 33.8%
- 13.2%
- 6.0%
- –
- 8.7%
- 10.0%
- –
- –
- –
- –
Growth
- +13.3%
- +11.9%
- –
- –
- +0.9%
Financial health
- 2.0×
- 0.57
- –
- 4.2×
- 1.22
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 34%of 946
Top 40%of 872
Top 24%of 563
Top 43%of 868
Bottom 13%of 986
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
40No pass
Benjamin Graham
58No pass
Philip Fisher
47No pass
Peter Lynch
54No pass
Joel Greenblatt
34No pass
Charlie Munger
30No pass
Terry Smith
22No pass
Questions about PT Medikaloka Hermina Tbk
Is PT Medikaloka Hermina Tbk a good stock to buy?
A business with weak numbers at a fair price. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the PT Medikaloka Hermina Tbk AI analysis
What does PT Medikaloka Hermina Tbk do?
PT Medikaloka Hermina Tbk, together with its subsidiaries, operates a network of hospitals in Indonesia. It is in Medical Care Facilities.
Is PT Medikaloka Hermina Tbk stock halal?
No. PT Medikaloka Hermina Tbk does not pass our halal screen: its debt is 43% of its market value, at or above the 33% limit. How we check
How has PT Medikaloka Hermina Tbk stock done over the past year?
Down 65.8% over the past twelve months, to IDR 494.00. It traded between IDR 468.00 and IDR 1,465.00 and is 66.3% below its high.
Who are PT Medikaloka Hermina Tbk's competitors?
The largest listed companies in the same industry are HCA Healthcare, Fresenius SE & Co. KGaA, IHH Healthcare Berhad and Rede D'Or São Luiz. The peers table on this page compares their profit, growth and price with PT Medikaloka Hermina Tbk's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.